NAMI
FOLD

Nomura Asset Management International’s Amicus Therapeutics FOLD Stock Holding History

Nomura Asset Management International’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.5M Sell
3,559,972
-1,509,618
-30% -$21.6M 0.09% 321
2025
Q4 		$72.2M Buy
+5,069,590
New +$49.8M 0.11% 248

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Nomura Asset Management International's FOLD Position: Q1 2026 in Review

Nomura Asset Management International reduced its Amicus Therapeutics (FOLD) stake by 30% in Q1 2026, selling an estimated $21.6M and leaving 3,559,972 shares worth $51.5M. The position accounts for 0.09% of the portfolio, ranked #321.

Nomura Asset Management International first reported a position in FOLD in Q4 2025 and has held it in 2 quarters since. The position peaked at $72.2M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Nomura Asset Management International held 3,559,972 shares of Amicus Therapeutics worth $51.5M as of Q1 2026.
  • Nomura Asset Management International sold 1,509,618 Amicus Therapeutics shares in Q1 2026, an estimated $21.6M.
  • Amicus Therapeutics made up 0.09% of Nomura Asset Management International's portfolio in Q1 2026, its #321 holding.
  • Nomura Asset Management International first reported a position in Amicus Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Nomura Asset Management International's Amicus Therapeutics position peaked at $72.2M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Nomura Asset Management International's 13F filing for Q1 2026, filed 15 May 2026.